Hormones Worsen ADHD: New Study Reveals Link

A pioneering study by academics at Queen Mary University and King's College London is investigating the significant, yet under-researched, link between women's hormonal cycles and ADHD symptoms. Many women report that their ADHD medication becomes less effective at certain times of the month, a phenomenon attributed to hormone fluctuations impacting neurotransmitters like dopamine.

Historically, ADHD diagnostic criteria were based primarily on male symptoms, often overlooking the inattentive or masked presentations common in girls and women. Hormonal shifts during perimenopause or pregnancy can exacerbate these symptoms. Early findings from a Dutch clinic in 2023 showed that increasing medication dosage premenstrually improved symptoms in nine women, suggesting potential individualized treatment adjustments.

Despite anecdotal evidence and social media discussions, robust research has been slow to emerge. Experts emphasize listening to women's lived experiences while awaiting clinical translation of research findings. In the UK, severe waiting lists for ADHD assessments, some up to 10 years, highlight the need for accessible information and support, often spread through personal networks and online platforms.

Women with ADHD often internalize struggles, attributing them to personal failings rather than physiological factors. Research like the King's College study aims to empower individuals with evidence, validating their experiences and combating self-blame. Psychiatrist Sally Cubbin suggests dopamine dips during cycles may lead to riskier behavior, while Dr. Shevonne Matheiken prefers to frame it as impulsivity or executive dysfunction, stressing a non-judgmental approach.

Ultimately, understanding these hormonal influences allows women to be kinder to themselves, acknowledging that consistent peak performance is not always achievable. This acceptance, though challenging, is crucial for managing ADHD effectively while awaiting further treatment advancements.